CHD8 dosage regulates transcription in pluripotency and early murine neural differentiation

33Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

The chromatin remodeler CHD8 is among the most frequently mutated genes in autism spectrum disorder (ASD). CHD8 has a dosagesensitive role in ASD, but when and how it becomes critical to human social function is unclear. Here, we conducted genomic analyses of heterozygous and homozygous Chd8 mouse embryonic stem cells and differentiated neural progenitors. We identify dosage-sensitive CHD8 transcriptional targets, sites of regulated accessibility, and an unexpected cooperation with SOX transcription factors. Collectively, our findings reveal that CHD8 negatively regulates expression of neuronal genes to maintain pluripotency and also during differentiation. Thus, CHD8 is essential for both the maintenance of pluripotency and neural differentiation, providing mechanistic insight into its function with potential implications for ASD.

Cite

CITATION STYLE

APA

Sood, S., Webera, C. M., Hodges, H. C., Krokhotin, A., Shalizi, A., & Crabtree, G. R. (2020). CHD8 dosage regulates transcription in pluripotency and early murine neural differentiation. Proceedings of the National Academy of Sciences of the United States of America, 117(36), 22331. https://doi.org/10.1073/pnas.1921963117

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free